137 related articles for article (PubMed ID: 19054856)
1. Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Haldane J
BJOG; 2008 Nov; 115(12):1587-8; author reply 1588-9. PubMed ID: 19054856
[No Abstract] [Full Text] [Related]
2. Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Gomperts R; Kleiverda G; Gemzell K; Davies S; Jelinska K
BJOG; 2008 Nov; 115(12):1578-9. PubMed ID: 19035995
[No Abstract] [Full Text] [Related]
3. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Gomperts RJ; Jelinska K; Davies S; Gemzell-Danielsson K; Kleiverda G
BJOG; 2008 Aug; 115(9):1171-5; discussion 1175-8. PubMed ID: 18637010
[TBL] [Abstract][Full Text] [Related]
4. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India.
Ganatra B; Manning V; Pallipamulla SP
Reprod Health Matters; 2005 Nov; 13(26):65-74. PubMed ID: 16291487
[TBL] [Abstract][Full Text] [Related]
5. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives.
Tamang A; Tamang J
Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492
[TBL] [Abstract][Full Text] [Related]
6. Online access to abortion medications: a review of utilization and clinical outcomes.
Endler M; Cleeve A; Gemzell-Danielsson K
Best Pract Res Clin Obstet Gynaecol; 2020 Feb; 63():74-86. PubMed ID: 31383555
[TBL] [Abstract][Full Text] [Related]
7. In brief: Mifepristone by mail for pregnancy termination.
Med Lett Drugs Ther; 2022 Jan; 64(1642):11. PubMed ID: 35134042
[No Abstract] [Full Text] [Related]
8.
Fuleihan C
Am J Law Med; 2020 Nov; 46(4):507-517. PubMed ID: 33413017
[No Abstract] [Full Text] [Related]
9. Improving access to safe abortion in a rural primary care setting in India: experience of a service delivery intervention.
Iyengar K; Iyengar SD
Reprod Health; 2016 May; 13(1):54. PubMed ID: 27165519
[TBL] [Abstract][Full Text] [Related]
10. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
[TBL] [Abstract][Full Text] [Related]
11. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
[TBL] [Abstract][Full Text] [Related]
12. Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.
Løkeland M; Bjørge T; Iversen OE; Akerkar R; Bjørge L
Int J Epidemiol; 2017 Apr; 46(2):643-651. PubMed ID: 28031316
[TBL] [Abstract][Full Text] [Related]
13. FDA considering restricted access to "abortion pill".
Sibbald B
CMAJ; 2000 Sep; 163(5):586. PubMed ID: 11006770
[No Abstract] [Full Text] [Related]
14. A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
Chai J; Ho PC
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):291-4. PubMed ID: 24135383
[TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
16. [Medical abortion provided by telemedicine to women in Latin America: complications and their treatment].
Larrea S; Palència L; Perez G
Gac Sanit; 2015; 29(3):198-204. PubMed ID: 25770915
[TBL] [Abstract][Full Text] [Related]
17. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
18. The combination of mifepristone and misoprostol for the termination of pregnancy.
;
Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
[TBL] [Abstract][Full Text] [Related]
19. Re: Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial.
Lyus R
BJOG; 2011 Aug; 118(9):1148-9. PubMed ID: 21749622
[No Abstract] [Full Text] [Related]
20. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
Rose SB; Shand C; Simmons A
Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]